If you choose to use a GLP-1, Im going to help you navigate your diet with science-backed info
The insulinotropic and glucagon-suppressing effects of GLP-1 agonists directly address these goals, making them an established component of diabetes treatment algorithms
For example, many populations are not meeting the recommendations for fibre intake including those in Argentina, Canada, China, Lithuania, South Africa, the UK, and US
Wegovy (semaglutide) Approved - An injectable GLP-1 receptor agonist approved for chronic weight management
The long-acting analoguesparticularly semaglutide and tirzepatideachieve the greatest reductions in glycated hemoglobin and body weight, while liraglutide and dulaglutide show moderate but clinically relevant benefits
Discuss this distinction with your provider before choosing